MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/joa3.13070

Медицинская библиотека · Journal of arrhythmia · 2024

The impact of hyperbaric oxygen treatment for cardiovascular implantable electronic devices.

Goto Kentaro, Miyazaki Shinsuke, Oyaizu Takuya, Negishi Miho, Ikenouchi Takashi, Yamamoto Tasuku, Kawamura Iwanari, Nishimura Takuro, Takamiya Tomomasa, Tao Susumu, Takigawa Masateru, Yagishita Kazuyoshi, Sasano Tetsuo

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

The safety of hyperbaric oxygen treatment (HBO2) in patients with cardiovascular implanted electronic devices (CIED) remains unclear.

METHODS

We conducted a retrospective analysis of seven CIED patients (median age 79 [73-83] years, five males [71.4%]), including five with pacemakers and two with implantable cardioverter defibrillators (ICD), who underwent HBO2 between June 2013 and April 2023. During the initial session, electrocardiogram monitoring was conducted, and CIED checks were performed before and after the treatment. In addition, the medical records were scrutinized to identify any abnormal CIED operations.

RESULTS

All seven CIED patients underwent HBO2 within the safety pressure range specified by the CIED manufacturers or general pressure test by the International Organization for Standardization (2.5 [2.5-2.5] atmosphere absolute × 18 [5-20] sessions). When comparing the CIED parameters before and after HBO2, no significant changes were observed in the waveform amplitudes, pacing thresholds, lead impedance of the atrial and ventricular leads, or battery levels. All seven patients, including two with the rate response function activated, exhibited no significant changes in the pacing rate or pacing failure. Two ICD patients did not deactivate the therapy, including the defibrillation; however, they did not experience any arrhythmia or inappropriate ICD therapy during the HBO2.

CONCLUSION

CIED patients who underwent HBO2 within the safety pressure range exhibited no significant changes in the parameters immediately after the HBO2 and had no observable abnormal CIED operations during the treatment. The safety of defibrillation by an ICD during HBO2 should be clarified.

Для цитирования: Goto Kentaro, Miyazaki Shinsuke, Oyaizu Takuya, Negishi Miho, Ikenouchi Takashi, Yamamoto Tasuku, Kawamura Iwanari, Nishimura Takuro, Takamiya Tomomasa, Tao Susumu, Takigawa Masateru, Yagishita Kazuyoshi, Sasano Tetsuo. The impact of hyperbaric oxygen treatment for cardiovascular implantable electronic devices.. Journal of arrhythmia. 2024. DOI: 10.1002/joa3.13070.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.